Pennant Investors’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-128,400	Closed	-$299K	–	18
2024 Q2	$299K	Hold	128,400	–	–	0.08%	30
2024 Q1	$574K	Hold	128,400	–	–	0.14%	19
2023 Q4	$412K	Buy	+128,400	New	+$412K	0.09%	25